The Missing Link?
By abolishing the obstruction created by a highly stenotic aortic valve, transcatheter aortic valve replacement (TAVR) is an effective treatment for severe aortic stenosis, with a hemodynamic profile (mean gradient and aortic valve area) at least similar or even superior to conventional surgical aortic valve replacement (1). However, the presence of paravalvular leak (PVL) after TAVR has been shown to be associated with increased mortality (2) . Although a negative impact on left ventricular recovery and remodeling has been proposed as the primary causal mechanism (3), the exact pathophysiology of PVL and its association with increased mortality remains to be completely understood. 
B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N
I S S N 1 9 3 6 -8 7 9 8 / $ 3 6 . 0 0
